Browse drugs

…Recent studies have indicated that Janus kinase inhibitors (JAKi) exert context-dependent immunomodulatory effects in cancer imm…

…Background Although immune checkpoint inhibitors (ICIs) have long half-lives, preclinical and retrospective clinical s…

…en derive comparable benefit from immune checkpoint inhibitors (ICIs) in advanced non-small cell lung cancer (NSCLC) remains uncerta…

…erapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients with interstitial lung disease and non-small cell…

…Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, offering durable res…

…d microRNAs from 79 patients with metastatic NSCLC treated with immune checkpoint inhibitors (ICIs). High-dimensional omics data were integrated using Multi…

…bits remarkable susceptibility to immune checkpoint inhibitors (ICIs), with responses in approximately half of patients with advance…

…Background Immune checkpoint inhibitors (ICIs) are increasingly used in adolescents and young adults (AYAs) w…

…C) present a significant challenge due to poor prognosis. While immune checkpoint inhibitors (ICIs) have been standard treatments for NSCLC, their efficacy …

…Background Immune checkpoint inhibitors (ICIs) have transformed the treatment strategy for bladder cancer (BL…

…Objective Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment but can cause several imm…

…Introduction Immune checkpoint inhibitors (ICIs) have become an important treatment option for selected cancer …